A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/EB2293DB.svg?ark=w1%2F20260515%2FEB2293DB)](https://nobleid.org/work/w1/20260515/EB2293DB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors